VIA
TWST icon

Vident Investment Advisory’s Twist Bioscience TWST Stock Holding History

Vident Investment Advisory’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-10,205
Closed -$209K – 986
2023
Q2 		$209K Buy
+10,205
New +$153K 0.01% 1045
2021
Q3 		– Sell
-1,757
Closed -$234K – 1237
2021
Q2 		$234K Buy
+1,757
New +$204K 0.01% 998

Other funds holding TWST

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Vident Investment Advisory's TWST Position: Q3 2023 in Review

Vident Investment Advisory sold out of Twist Bioscience (TWST) in Q3 2023, closing a stake of 10,205 shares — an estimated $209K sold.

Vident Investment Advisory first reported a position in TWST in Q2 2021 and held it in 2 quarters. The position peaked at $234K in Q2 2021. 194 funds tracked by Wall St. Rank hold TWST as of Q3 2023.

  • Vident Investment Advisory reported no remaining Twist Bioscience position as of Q3 2023 after selling out during the quarter.
  • Vident Investment Advisory sold 10,205 Twist Bioscience shares in Q3 2023, an estimated $209K.
  • Vident Investment Advisory first reported a position in Twist Bioscience in Q2 2021 and held it in 2 quarters.
  • Vident Investment Advisory's Twist Bioscience position peaked at $234K in Q2 2021.
  • 194 funds tracked by Wall St. Rank held Twist Bioscience as of Q3 2023.

Based on Vident Investment Advisory's 13F filing for Q3 2023.